Cargando…
Strategies for eliciting and synthesizing evidence for guidelines in rare diseases
BACKGROUND: Rare diseases are a global public health priority. Though each disease is rare, when taken together the thousands of known rare diseases cause significant morbidity and mortality, impact quality of life, and confer a social and economic burden on families and communities. These condition...
Autores principales: | Pai, Menaka, Yeung, Cindy H. T., Akl, Elie A., Darzi, Andrea, Hillis, Christopher, Legault, Kimberly, Meerpohl, Joerg J., Santesso, Nancy, Taruscio, Domenica, Verhovsek, Madeleine, Schünemann, Holger J., Iorio, Alfonso |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437842/ https://www.ncbi.nlm.nih.gov/pubmed/30922227 http://dx.doi.org/10.1186/s12874-019-0713-0 |
Ejemplares similares
-
Developing methodology for the creation of clinical practice guidelines for rare diseases: A report from RARE-Bestpractices
por: Pai, Menaka, et al.
Publicado: (2015) -
Improving the trustworthiness of findings from nutrition evidence syntheses: assessing risk of bias and rating the certainty of evidence
por: Schwingshackl, Lukas, et al.
Publicado: (2020) -
Methods used in adaptation of health–related guidelines: A systematic survey
por: Abdul–Khalek, Rima A, et al.
Publicado: (2017) -
Using GRADE in situations of emergencies and urgencies: certainty in evidence and recommendations matters during the COVID-19 pandemic, now more than ever and no matter what
por: Schünemann, Holger J., et al.
Publicado: (2020) -
GRADE guidance 24 optimizing the integration of randomized and non-randomized studies of interventions in evidence syntheses and health guidelines
por: Cuello-Garcia, Carlos A., et al.
Publicado: (2022)